PPARA and arteriosclerosis disorder: Other studies showed that BCA, as an effective peroxisome proliferator-activated receptor α (PPARα) agonist, can improve the arteriosclerosis of diabetic complications by activating PPARα, which is effective in the treatment of diabetes [36].